APA (7th ed.) Citation

Lodise, T. P., Colman, S., Alexander, E., Stein, D. S., Fitts, D., Goldberg, L., & Schranz, J. (2020). Health-Related Quality of Life as Measured by the 12-Item Short-Form Survey Among Adults With Community-Acquired Bacterial Pneumonia who Received Either Lefamulin or Moxifloxacin in 2 Phase III Randomized, Double-Blind, Double-Dummy Clinical Trials. Open Forum Infectious Diseases, 7(6), 1. https://doi.org/10.1093/ofid/ofaa209

Chicago Style (17th ed.) Citation

Lodise, Thomas P., Sam Colman, Elizabeth Alexander, Daniel S. Stein, David Fitts, Lisa Goldberg, and Jennifer Schranz. "Health-Related Quality of Life as Measured by the 12-Item Short-Form Survey Among Adults With Community-Acquired Bacterial Pneumonia Who Received Either Lefamulin or Moxifloxacin in 2 Phase III Randomized, Double-Blind, Double-Dummy Clinical Trials." Open Forum Infectious Diseases 7, no. 6 (2020): 1. https://doi.org/10.1093/ofid/ofaa209.

MLA (9th ed.) Citation

Lodise, Thomas P., et al. "Health-Related Quality of Life as Measured by the 12-Item Short-Form Survey Among Adults With Community-Acquired Bacterial Pneumonia Who Received Either Lefamulin or Moxifloxacin in 2 Phase III Randomized, Double-Blind, Double-Dummy Clinical Trials." Open Forum Infectious Diseases, vol. 7, no. 6, 2020, p. 1, https://doi.org/10.1093/ofid/ofaa209.